Sale!

Cancer Targeted Gene Panel CNS Tumor Test

Original price was: 5,200 د.إ.Current price is: 4,680 د.إ.

-10%

The “Cancer Targeted Gene Panel CNS Tumor Test” is a specialized diagnostic tool available at DNA Labs UAE, designed to analyze specific genes associated with central nervous system (CNS) tumors. This advanced genetic test aims to identify mutations within a select panel of genes that are known to play a significant role in the development, progression, and response to treatment of CNS tumors. By pinpointing these genetic alterations, healthcare providers can tailor more effective and personalized treatment plans for patients, potentially improving outcomes. The test is priced at 4680 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results for patients and their families. This test represents a crucial step forward in the field of precision medicine, offering hope for better management of CNS tumors through targeted therapeutic strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Cancer Targeted Gene Panel CNS Tumor Test

At DNA Labs UAE, we offer the Cancer Targeted Gene Panel CNS Tumor Test, a genetic test designed to identify mutations and alterations in genes associated with central nervous system (CNS) tumors. This test is crucial in the diagnosis and treatment decision-making process for individuals with CNS tumors, including brain tumors and spinal cord tumors.

Test Details

The Cancer Targeted Gene Panel CNS Tumor Test is a comprehensive analysis that examines genes frequently mutated in CNS tumors. By identifying specific genetic abnormalities, this test provides valuable information that can guide personalized treatment options and improve patient outcomes.

Test Components

  • 1p19q codeletion
  • EGFR amplification
  • IDH1, IHC
  • Ki67
  • ATRX
  • TP53
  • IDH1 & 2 mutation
  • PTEN
  • BRAF

Test Price

The cost of the Cancer Targeted Gene Panel CNS Tumor Test is 4680.0 AED.

Sample Condition

To conduct the test, please submit a formalin-fixed paraffin-embedded tissue block. Ensure that the sample is shipped at room temperature. Additionally, a duly filled NGS Test Requisition Form is mandatory.

Report Delivery

The sample is required to be submitted by Tuesday at 9 am. The report will be delivered within 10 working days.

Method

The Cancer Targeted Gene Panel CNS Tumor Test utilizes immunohistochemistry (IHC), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH) techniques.

Test Type

The Cancer Targeted Gene Panel CNS Tumor Test is specifically designed for cancer-related genetic analysis.

Doctor

For this test, it is recommended to consult with an oncologist.

Test Department

The Cancer Targeted Gene Panel CNS Tumor Test is conducted in our Cytogenetics department.

Pre Test Information

Prior to the test, it is mandatory to fill out the NGS Test Requisition Form.

By choosing DNA Labs UAE for your Cancer Targeted Gene Panel CNS Tumor Test, you can gain valuable insights into the genetic abnormalities present in your CNS tumor. This information can help guide personalized treatment options, leading to improved patient outcomes. Contact us today to schedule your test.

Test Name CANCER TARGETED GENE PANEL CNS TUMOR Test
Components *1p19q codeletion *EGFR amplification *IDH1, IHC*Ki67*ATRX*TP53*IDH1 & 2 mutation *PTEN*BRAF
Price 4680.0 AED
Sample Condition Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Duly filled NGS Test Requisition Formis mandatory.
Report Delivery Sample Tue by 9 am; Report 10 Working days
Method IHC, NGS, FISH
Test type Cancer
Doctor Oncologist
Test Department: CYTOGENETICS
Pre Test Information Duly filled NGS Test Requisition Formis mandatory.
Test Details

The Cancer Targeted Gene Panel CNS Tumor Test is a genetic test that specifically looks for mutations and alterations in genes associated with central nervous system (CNS) tumors. This test is used to help diagnose and guide treatment decisions for individuals with CNS tumors, such as brain tumors or spinal cord tumors. The panel includes genes that are known to be frequently mutated in CNS tumors, allowing for a comprehensive analysis of potential genetic abnormalities. The results of this test can provide important information about the specific genetic alterations present in a patient’s tumor, which can help guide personalized treatment options and improve patient outcomes.